Drawing for DERMACURE

USPTO serial 76590040

DERMACURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCCRAY, RENEE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DERMACURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bernard W. Gerdelman

Bernard W. Gerdelman PAULE, CAMAZINE & BLUMENTHAL, P.C.165 NORTH MERAMEC, SIXTH FLOORSt. Louis, MO 63105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005medicated skin care preparations and lotionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 8, 2008MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 8, 2008ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 16, 2007EX5GSOU EXTENSION 5 GRANTED—
Nov 16, 2007EXT5SOU EXTENSION 5 FILED—
Nov 16, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 23, 2007EX4GSOU EXTENSION 4 GRANTED—
May 14, 2007EXT4SOU EXTENSION 4 FILED—
May 14, 2007MAILPAPER RECEIVED—
Apr 18, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 3, 2007EX3GSOU EXTENSION 3 GRANTED—
Nov 9, 2006EXT3SOU EXTENSION 3 FILED—
Nov 9, 2006MAILPAPER RECEIVED—
Aug 16, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 9, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 6, 2006EX2GSOU EXTENSION 2 GRANTED—
May 17, 2006MAILPAPER RECEIVED—
May 15, 2006EXT2SOU EXTENSION 2 FILED—
Dec 14, 2005EX1GSOU EXTENSION 1 GRANTED—
Nov 18, 2005MAILPAPER RECEIVED—
Nov 14, 2005EXT1SOU EXTENSION 1 FILED—
May 17, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 22, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 2, 2005NPUBNOTICE OF PUBLICATION—
Dec 16, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 14, 2004ALIEASSIGNED TO LIE—
Dec 10, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2004CNEAEXAMINER'S AMENDMENT MAILED—
Nov 28, 2004CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 28, 2004DOCKASSIGNED TO EXAMINER—
May 18, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance